World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
42692
World Ranking
10705
National Ranking
5503

Michael M. Givertz publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Michael M. Givertz sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 409 publications — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Michael M. Givertz D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Michael M. Givertz sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 93 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Michael M. Givertz is affiliated with Brigham and Women's Hospital in the United States. Their research spans a variety of topics primarily within medicine, with particular focus on surgery, cardiology and cardiovascular medicine, biomedical engineering, emergency medicine, and transplantation.

Their recent published papers include the following:

  • Transplantation Outcomes with Donor Hearts after Circulatory Death, 2023, New England Journal of Medicine
  • Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction, 2021, JAMA Cardiology
  • Marijuana Use in Patients With Cardiovascular Disease, 2020, Journal of the American College of Cardiology
  • Trends and Outcomes of Left Ventricular Assist Device Therapy, 2022, Journal of the American College of Cardiology
  • Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure, 2023, JAMA

The research topics covered by Michael M. Givertz include:

  • Mechanical Circulatory Support Devices
  • Cardiac Structural Anomalies and Repair
  • Transplantation: Methods and Outcomes
  • Heart Failure Treatment and Management
  • Cardiac Arrest and Resuscitation
  • Renal Transplantation Outcomes and Treatments
  • Organ Transplantation Techniques and Outcomes

They frequently collaborate with several coauthors, notably:

  • Mandeep R. Mehra
  • Ersilia M. DeFilippis
  • Hari R. Mallidi
  • Garrick C. Stewart
  • Ann E. Woolley

Michael M. Givertz's work is published predominantly in the following venues:

  • The Journal of Heart and Lung Transplantation
  • Journal of Cardiac Failure
  • JACC Heart Failure
  • Circulation Heart Failure
  • Journal of the American College of Cardiology

Their research combines clinical medicine with surgical and engineering approaches to address complex cardiovascular conditions and transplantation challenges. The focus on mechanical circulatory support and heart failure treatment highlights a commitment to advancing both therapeutic methods and patient outcomes within cardiovascular care and organ transplantation.

Best Publications

  • 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

    Clyde W. Yancy;Mariell Jessup;Biykem Bozkurt;Javed Butler

  • Diuretic Strategies in Patients with Acute Decompensated Heart Failure

    G. Michael Felker;Kerry L. Lee;David A. Bull;Margaret M. Redfield

  • HFSA 2010 Comprehensive Heart Failure Practice Guideline.

    Lindenfeld J;Albert Nm;Boehmer Jp

  • Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

    W S Colucci;U Elkayam;D P Horton;W T Abraham

  • Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: A randomized clinical trial

    Margaret M. Redfield;Horng H. Chen;Barry A. Borlaug;Marc J. Semigran

  • Ultrafiltration in decompensated heart failure with cardiorenal syndrome

    Bradley A. Bart;Steven R. Goldsmith;Kerry L. Lee;Michael M. Givertz

  • 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

    Clyde W. Yancy;Mariell Jessup;Biykem Bozkurt;Javed Butler

  • 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

    Clyde W. Yancy;Mariell Jessup;Biykem Bozkurt;Javed Butler

  • 2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: Endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d’intervention

    Charanjit S. Rihal;Srihari S. Naidu;Michael M. Givertz;Wilson Y. Szeto

  • 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

    Clyde W. Yancy;Mariell Jessup;Biykem Bozkurt;Javed Butler

  • Consensus recommendations for the management of chronic heart failure: Introduction

    Milton Packer;Jay N. Cohn;William T. Abraham;Wilson S. Colucci

  • Genetic Evaluation of Cardiomyopathy-A Heart Failure Society of America Practice Guideline

    Ray E. Hershberger;Michael M. Givertz;Carolyn Y. Ho;Daniel P. Judge

  • Admission B-Type Natriuretic Peptide Levels and In-Hospital Mortality in Acute Decompensated Heart Failure

    Gregg C. Fonarow;William F. Peacock;Christopher O. Phillips;Michael M. Givertz

  • Rolofylline, an Adenosine A1−Receptor Antagonist, in Acute Heart Failure

    Barry M. Massie;Christopher M. O'Connor;Marco Metra;Piotr Ponikowski

  • Secondary Pulmonary Hypertension in Chronic Heart Failure: The Role of the Endothelium in Pathophysiology and Management

    Denzil L. Moraes;Wilson S. Colucci;Michael M. Givertz

  • Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial

    Kenneth B Margulies;Adrian F Hernandez;Margaret M Redfield;Michael M Givertz

  • Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial.

    Horng H. Chen;Kevin J. Anstrom;Michael M. Givertz;Lynne W. Stevenson

  • Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update

    Shannon M. Dunlay;Michael M. Givertz;David Aguilar;Larry A. Allen

  • Impact of Oxypurinol in Patients With Symptomatic Heart Failure. Results of the OPT-CHF Study

    Joshua M Hare Md;Brian Mangal MSc;Joanne Brown BSc;Charles Fisher Md

  • Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial.

    Gregory D Lewis;Rajeev Malhotra;Adrian F Hernandez;Steven E McNulty

Frequent Co-Authors

John R. Teerlink
John R. Teerlink University of California, San Francisco
Marco Metra
Marco Metra University of Brescia
Adriaan A. Voors
Adriaan A. Voors University Medical Center Groningen
Piotr Ponikowski
Piotr Ponikowski Wrocław Medical University
John G.F. Cleland
John G.F. Cleland University of Glasgow
Lynne W. Stevenson
Lynne W. Stevenson Vanderbilt University Medical Center
Gad Cotter
Gad Cotter Momentum Research Inc
Mandeep R. Mehra
Mandeep R. Mehra Brigham and Women's Hospital
Akshay S. Desai
Akshay S. Desai Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always require a traditional MD path. Today, there are diverse online options to help you enter or advance in the healthcare field. For those seeking to enter patient care quickly, fast track medical programs for Licensed Practical Nurses (LPNs) provide accelerated routes with flexible online study.

If you’re interested in mental health, consider psych np programs, which prepare nurses for specialized roles as psychiatric mental health nurse practitioners. These advanced nursing degrees can often be completed online for increased convenience.

Healthcare administration is another growing field with significant career potential. Studying for a health care administration degree online provides essential skills in management, finance, and policy for the healthcare environment. Those seeking leadership roles might pursue affordable mha online programs to earn a Master’s in Healthcare Administration at a manageable cost.

Each of these online degree options offers distinct pathways toward meaningful and in-demand careers in the health sector. Choose the route that fits your goals, timeline, and interests to shape your future in healthcare.

Best Scientists Citing Michael M. Givertz

Trending Scientists

Recently Published Articles